Jason Duncan
First SEC filing: May 30, 2025 · Latest: May 30, 2025
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 20, 2026 | NMRA | A | 375,000 | · | · | 375,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 8, 2026 | NMRA | A | 750,000 | · | · | 750,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 28, 2025 | NMRA | A | 500,000 | · | · | 500,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 28, 2025 | NMRA | A | 400,000 | · | · | 400,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 28, 2025 | NMRA | D | 500,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| May 28, 2025 | NMRA | D | 400,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Feb. 13, 2025 | NMRA | A | 400,000 | · | · | 400,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 13, 2025 | NMRA | D | 400,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Feb. 13, 2025 | NMRA | A | 500,000 | · | · | 500,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 11, 2023 | NMRA | A | 400,000 | · | · | 400,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 20, 2026 | NMRA | Stock Option (Right to Buy) | Common Stock | $1.52 | Aug. 20, 2036 | 375,000 | Acquired |
| Jan. 8, 2026 | NMRA | Stock Option (Right to Buy) | Common Stock | $2.33 | Jan. 8, 2036 | 750,000 | Acquired |
| May 28, 2025 | NMRA | Stock Option (Right to Buy) | Common Stock | · | Feb. 13, 2035 | 500,000 | Acquired |
| May 28, 2025 | NMRA | Stock Option (Right to Buy) | Common Stock | · | Dec. 11, 2033 | 400,000 | Acquired |
| May 28, 2025 | NMRA | Stock Option (Right to Buy) | Common Stock | $1.69 | Feb. 13, 2035 | 500,000 | Disposed |
| May 28, 2025 | NMRA | Stock Option (Right to Buy) | Common Stock | $1.69 | Dec. 11, 2033 | 400,000 | Disposed |
| Feb. 13, 2025 | NMRA | Stock Option (Right to Buy) | Common Stock | · | Dec. 11, 2033 | 400,000 | Acquired |
| Feb. 13, 2025 | NMRA | Stock Option (Right to Buy) | Common Stock | $12.97 | Dec. 11, 2033 | 400,000 | Disposed |
| Feb. 13, 2025 | NMRA | Stock Option (Right to Buy) | Common Stock | $1.69 | Feb. 13, 2035 | 500,000 | Acquired |
| Dec. 11, 2023 | NMRA | Stock Option (Right to Buy) | Common Stock | $12.97 | Dec. 10, 2033 | 400,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $26,250 | · | · | · | · | · | · | $4,119,980 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.